Minosse, C.; Spezia, P.G.; Mazzotta, V.; Matusali, G.; Meschi, S.; Colavita, F.; Mariotti, D.; Notari, S.; Vergori, A.; Focosi, D.;
et al. Assessing Torquetenovirus (TTV) as a Biomarker for Immune Responses to SARS-CoV-2 mRNA Vaccines in People Living with HIV and Healthy Individuals. Vaccines 2025, 13, 153.
https://doi.org/10.3390/vaccines13020153
AMA Style
Minosse C, Spezia PG, Mazzotta V, Matusali G, Meschi S, Colavita F, Mariotti D, Notari S, Vergori A, Focosi D,
et al. Assessing Torquetenovirus (TTV) as a Biomarker for Immune Responses to SARS-CoV-2 mRNA Vaccines in People Living with HIV and Healthy Individuals. Vaccines. 2025; 13(2):153.
https://doi.org/10.3390/vaccines13020153
Chicago/Turabian Style
Minosse, Claudia, Pietro Giorgio Spezia, Valentina Mazzotta, Giulia Matusali, Silvia Meschi, Francesca Colavita, Davide Mariotti, Stefania Notari, Alessandra Vergori, Daniele Focosi,
and et al. 2025. "Assessing Torquetenovirus (TTV) as a Biomarker for Immune Responses to SARS-CoV-2 mRNA Vaccines in People Living with HIV and Healthy Individuals" Vaccines 13, no. 2: 153.
https://doi.org/10.3390/vaccines13020153
APA Style
Minosse, C., Spezia, P. G., Mazzotta, V., Matusali, G., Meschi, S., Colavita, F., Mariotti, D., Notari, S., Vergori, A., Focosi, D., Girardi, E., Antinori, A., & Maggi, F.
(2025). Assessing Torquetenovirus (TTV) as a Biomarker for Immune Responses to SARS-CoV-2 mRNA Vaccines in People Living with HIV and Healthy Individuals. Vaccines, 13(2), 153.
https://doi.org/10.3390/vaccines13020153
